Mitsubishi Tanabe Pharma Corporation reported consolidated earnings results for the nine months ended December 31, 2019. For the period, the company reported revenue of ¥297,414 million against ¥332,479 million a year ago. Core operating profit was ¥24,187 million against ¥55,574 million a year ago. Operating profit was ¥24,984 million against ¥56,446 million a year ago. Profit for the period was ¥15,308 million against ¥38,010 million a year ago. Basic earnings per share was ¥32.50 against ¥73.95 a year ago. Diluted earnings per share was ¥32.49 against ¥73.95 a year ago.

For the year ending March 31, 2020, the company expects consolidated revenue of ¥376,000 million, core operating profit of ¥10,000 million, operating profit of ¥11,500 million and profit for the period of ¥4,000 million.

For the year ending March 31, 2020, the company expects not to pay dividend for the period against ¥28.00 per share paid a year ago.